Ghost Tree Capital’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-11,500
Closed -$187K 48
2019
Q4
$187K Buy
+11,500
New +$272K 0.04% 51
2019
Q2
Sell
-115,000
Closed -$8.4M 44
2019
Q1
$8.4M Sell
115,000
-25,000
-18% -$1.73M 2.19% 20
2018
Q4
$8.93M Buy
140,000
+80,000
+133% +$5.95M 3.24% 9
2018
Q3
$5.99M Buy
60,000
+44,300
+282% +$3.68M 1.27% 28
2018
Q2
$1.11M Buy
15,700
+6,700
+74% +$562K 0.33% 36
2018
Q1
$937K Buy
+9,000
New +$1.01M 0.19% 51

Other funds holding ANAB

Ghost Tree Capital's ANAB Position: Q1 2020 in Review

Ghost Tree Capital sold out of AnaptysBio (ANAB) in Q1 2020, closing a stake of 11,500 shares — an estimated $187K sold.

Ghost Tree Capital first reported a position in ANAB in Q1 2018 and held it in 6 quarters. The position peaked at $8.93M in Q4 2018. 116 funds tracked by Wall St. Rank hold ANAB as of Q1 2020.

  • Ghost Tree Capital reported no remaining AnaptysBio position as of Q1 2020 after selling out during the quarter.
  • Ghost Tree Capital sold 11,500 AnaptysBio shares in Q1 2020, an estimated $187K.
  • Ghost Tree Capital first reported a position in AnaptysBio in Q1 2018 and held it in 6 quarters.
  • Ghost Tree Capital's AnaptysBio position peaked at $8.93M in Q4 2018.
  • 116 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2020.

Based on Ghost Tree Capital's 13F filing for Q1 2020, filed 15 May 2020.